| 1.
| Gilman, A.G., Rail, T.W., Nies, A.S., and Taylor, P. (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York, Pergamon Press, (8th edn) 1990, p1402.
|
| 2.
| Berer, M., "Contraception", chapter 15 in: Phillips, A., Rakusen, J. (eds) and the Boston Women's Health Collective, The New Our Bodies, Ourselves (2nd UK edition), London, Penguin Books, 1989, p290.
|
| 3.
| LaCheen, C., "Population control and the pharmaceutical industry", in: McDonnell, K. (ed.), Adverse Effects: Women and the Pharmaceutical Industry, Penang, IOCU, 1986, pl08.
|
| 4.
| Wharton, C. and Blackburn, R., "Lower-dose pills", Population Reports, Series A, No 7, Baltimore, Johns Hopkins University, Nov 1988, p1.
|
| 5.
| Anon., "ОС needs in developing countries", Scrip, No 1696, 28 Feb 1992, p21.
|
| 6.
| Anon., "Sobering AG's prospects", Scrip, No 1500, 28 Mar 1990, p1O.
|
| 7.
| Milne, R. and Vessey, M., "The pill and mortality - an overview", Journal of Public Health Medicine, Vol 14, No 1,1992, pp9-16.
|
| 8.
| Anon., "US use of OCs at highest level since 1975", Scrip, No 1653, 20 Sep 1991, p28.
|
| 9.
| Anon., The US Market for Selected Products Associated with Fertility & Infertility, New York, Frost & Sullivan, 1991.
|
| 10.
| Anon., "Decline of oral contraceptive use in Mexico", Scrip, No 1684, 17 Jan 1992, p20.
|
| 11.
| Wharton and Blackburn, 1988, op cit, p12.
|
| 12.
| Ibid, p13.
|
| 13.
| Finger, W.R., "Using oral contraceptives correctly: progress on package instructions", Network, Vol 12, No 2, Sep 1991, pp14-17 and 27; Potter, L.S., "Oral contraceptive compliance and its role in the effectiveness of the method", chapter 16 in: Caramer,J.A. and Spilker, B. (eds), Patient Compliance in Medical Practice and Clinical Trials, New York, Raven Press, 1991, pp195-207.
|
| 13a.
| Guillebaud, J., The Pill, Oxford University Press, (4th edn) 1991, pp58-65 and 209-14.
|
| 14.
| Gilmer, M.D.G., "Metabolic effects of combined oral contraceptives", chapter 2 in: Filshie, M. and Guillebaud, J. (eds), Contraception: Science and Practice, London, Butterwonh-Heinemann, 1989, pp31-2.
|
| 15.
| Guillebaud, J., op cit, p70.
|
| 16.
| Guillebaud, J., Contraception: у our questions answered, London, Churchill Livingstone, (revised edn) 1991, pp102-3 and 117.
|
| 17.
| Pike, M.C., Henderson, B.E., et al, "Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use"; and Vessey, M.P., Lawless, M., et al, "Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill", Lancet, No 8356, 22 Oct 1983, pp926-30 and 930-4.
|
| 18.
| UK National Case-control Study Group, "Oral contraceptive use and breast cancer risk in young women", Lancet, No 8645, 6 May 1989, pp973-82.
|
| 19.
| Romieu, I., Willett, W.C., et al, "Prospective study of oral contraceptive use and risk of breast cancer in women", Journal of the National Cancer Institute, Vol 81, No 17, 6 Sep 1989, pp1313-21.
|
| 20.
| Wingo, P.A., Lee, N.C., et al, "Age-specific differences in the relationship between oral contraceptive use and breast cancer", Obstetrics and Gynecology, Vol 78, No 2, Aug 1991, pp161-70.
|
| 21.
| Staffa, J.A., Newschaffer, C.J.,et al, "Progestins and breast cancer: an epidemiologic review", Fertility and Sterility, Vol 57, No 3, Mar 1992, pp473-91.
|
| 22.
| Harlap, S., "Oral contraceptives and breast cancer: cause and effect?", Journal of Reproductive Medicine, Vol 36, No 5, May 1991, pp374-95.
|
| 23.
| Thomas, D.B., "Oral contraceptives and breast cancer: review of the epidemiologic literature", Contraception, Vol 43, No 6, Jun 1991, pp597-642.
|
| 24.
| Szarewski, A. and Guillebaud, J., "Contraception: current state of the art", British Medical Journal, Vol 302, 25 May 1991, pp1224-6.
|
| 25.
| McPherson, К., "Combined progestin and estrogen (oral) and other forms of hormonal contraception", Current Opinion in Obstetrics and Gynecology, Vol 3, 1991, pp486-90.
|
| 26.
| Djerassi, С., "The bitter pill", Science, Vol 245, 28 Jul 1989, pp356-60.
|
| 27.
| Vessey, M.P., "Oral contraception and cancer", chapter 4 in: Pilshie and Guillebaud, 1989, op cit, p63.
|
| 28.
| Thomas, D.B., "The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries", Contraception, Vol 43, No 6, June 1991, pp695-710.
|
| 29.
| Guillebaud, 1991, Contraception, op cit, p43.
|
| 30.
| Arron., "Japan's wait for low dose 'pill", Lancet, Vol 339, 4 Apr 1992, p865.
|
| 31.
| Guillebaud, 1991, Contraception, op cit, p152.
|
| 32.
| Vessey, 1989, op cit, pp63-4; Hsing, A.W., Hoover, R.N., et al, "Oral contraceptive use and primary liver cancer among young women", C ancer Causes and Control, Vol 3, 1992, pp43-8.
|
| 33.
| AMA, Drug Evaluations, Philadelphia, W.B. Saunders Co., (6th edn) 1986, p724.
|
| 34.
| Parish, P., Medicines: a guide for everybody, London, Penguin (6th edn, revised), 1989, p247.
|
| 34a.
| BMA and the Royal Pharmaceutical Society of Great Britain, British National Formulary, London, BMA and The Pharmaceutical Press, No 23, Mar 1992, pp23\83 and 286.
|
| 35.
| Ibid, p240.
|
| 36.
| Berer, 1989, op cit, p292.
|
| 37.
| Drife, J., "Complications of combined oral contraception", chapter 3 in: Filshie and Guillebaud, 1989, op cit, p45.
|
| 38.
| Petitti, D.B. andPorterfield, D., "Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case and likely-case assumptions about the effect of oral contraceptive use", Contraception, Vol 45, No 2, Feb 1992, pp93-104.
|
| 39.
| Mishell Jr, D.R., "Contraception", New England Journal of Medicine, Vol 320, No 12, 23 Mar 1989, pp777-87.
|
| 40.
| Parish, 1989, op cit, p247.
|
| 41.
| Guillebaud, 1991, Contraception, op cit, p120.
|
| 42.
| AMA, 1986, op cit, p720.
|
| 43.
| Mishell, 1989, op cit, pp777-87.
|
| 44.
| Anon., "PDA warns ОС manufacturers", Scrip, No 1630, 3 Jul 1991, p18.
|
| 45.
| von Eickstedt, K.-W., "Sex hormones and related compounds including hormonal contraceptives", chapter 42 in: Dukes, M.N.G. and Beeley, L., (eds), Side Effects of Drugs Annual 14, Amsterdam, Elsevier, 1990, p349.
|
| 46.
| BMA and the Royal Pharmaceutical Society of Great Britain, 1992, op cit, p285.
|
| 47.
| Guillebaud, 1991, The Pill, op cit, p222.
|
| 47a.
| Lewis, P.J. and Hurden, E.L., "Breast feeding and drug treatment", in Hawkms,D.F. (ed.), Drugs and Pregnancy, London, Churchill Livingstone, (2nd edn) 1987, pp304-32.
|
| 48.
| Gilman, Rail, et al, 1990, op cit, p1409.
|
| 49.
| AMA, 1986, op cit, p723.
|
| 50.
| LaCheen, 1986, op cit, p108.
|
| 51.
| Guillebaud, 1991, Contraception, op cit, p127.
|
| 52.
| BMA and the Royal Pharmaceutical Society of Great Britain, 1992, op cit, p284.
|
| 53.
| Wharton, Blackburn, 1988, op cit, p9.
|
